PhotoCure ASA (LTS:0IMT)
kr 48.95 -0.35 (-0.71%) Market Cap: 1.34 Bil Enterprise Value: 1.05 Bil PE Ratio: 88.47 PB Ratio: 2.50 GF Score: 79/100

Photocure ASA at Needham Healthcare Conference (Virtual) Transcript

Apr 14, 2022 / 12:00PM GMT
Release Date Price: kr113.4
Chang Liu
Needham & Company, LLC - Analyst

Good morning and welcome to the 21st Needham healthcare conference. My name is Chang Liu, and I will be the moderator for this presentation. We welcome Photocure here today and its President and CEO, Dan Schneider. (Conference Instructions)

Without further ado, Dan, would you like to start your presentation?

Dan Schneider
Photocure ASA - President & CEO

I will. Thank you, Chang. Thank you, everyone, for joining today. I'm Dan Schneider, CEO and President of Photocure. You might tell by my accent, I am American. This is a Norwegian-based company.

For a reminder today, disclaimers are in effect for today's presentation. So a little bit about background of the company. The company has actually been around since 1990s -- 1990 and through the early 2000s. We are primarily focused on the R&D, research and development, of photosensitizing agents for both therapeutics and diagnostics.

We've transitioned ourselves, since myself joining the company, 3.5 years ago into a fully

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot